Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Teva Pharmaceutical (TEVA – Research Report), Novavax (NVAX – Research Report) and Sanofi (SNYNF – Research Report).
Teva Pharmaceutical (TEVA)
In a report released today, Thibault Boutherin from Morgan Stanley maintained a Hold rating on Teva Pharmaceutical, with a price target of $10.00. The company’s shares closed last Tuesday at $9.60.
According to TipRanks.com, Boutherin is ranked #3610 out of 8547 analysts.
Currently, the analyst consensus on Teva Pharmaceutical is a Hold with an average price target of $10.64, which is an 8.6% upside from current levels. In a report issued on September 20, UBS also maintained a Hold rating on the stock with a $11.00 price target.
See the top stocks recommended by analysts >>
Novavax (NVAX)
Bank of America Securities analyst Alec Stranahan maintained a Sell rating on Novavax yesterday and set a price target of $5.00. The company’s shares closed last Tuesday at $7.67, close to its 52-week low of $5.61.
According to TipRanks.com, Stranahan is a 4-star analyst with an average return of
Currently, the analyst consensus on Novavax is a Moderate Buy with an average price target of $24.00.
Sanofi (SNYNF)
In a report released today, Graham Parry from Bank of America Securities maintained a Buy rating on Sanofi, with a price target of $72.00. The company’s shares closed last Thursday at $105.47.
Parry has an average return of
According to TipRanks.com, Parry is ranked #3017 out of 8547 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sanofi with a $108.37 average price target, which is a 2.7% upside from current levels. In a report issued on September 26, Citi also maintained a Buy rating on the stock with a EUR138.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TEVA:
